Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Sickle Cell Disease
Clinical Trial
Last updated: 12/4/2025
Wayrilz
For the treatment of persistent or chronic immune thrombocytopenia (ITP)
SAN.PA
Sanofi
